Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint
Tineke Cantaert, … , Anne Durandy, Eric Meffre
Tineke Cantaert, … , Anne Durandy, Eric Meffre
Published October 4, 2016
Citation Information: J Clin Invest. 2016;126(11):4289-4302. https://doi.org/10.1172/JCI84645.
View: Text | PDF
Research Article Autoimmunity Article has an altmetric score of 1

Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint

  • Text
  • PDF
Abstract

Patients with mutations in AICDA, which encodes activation-induced cytidine deaminase (AID), display an impaired peripheral B cell tolerance. AID mediates class-switch recombination (CSR) and somatic hypermutation (SHM) in B cells, but the mechanism by which AID prevents the accumulation of autoreactive B cells in blood is unclear. Here, we analyzed B cell tolerance in AID-deficient patients, patients with autosomal dominant AID mutations (AD-AID), asymptomatic AICDA heterozygotes (AID+/–), and patients with uracil N-glycosylase (UNG) deficiency, which impairs CSR but not SHM. The low frequency of autoreactive mature naive B cells in UNG-deficient patients resembled that of healthy subjects, revealing that impaired CSR does not interfere with the peripheral B cell tolerance checkpoint. In contrast, we observed decreased frequencies of SHM in memory B cells from AD-AID patients and AID+/– subjects, who were unable to prevent the accumulation of autoreactive mature naive B cells. In addition, the individuals with AICDA mutations, but not UNG-deficient patients, displayed Tregs with defective suppressive capacity that correlated with increases in circulating T follicular helper cells and enhanced cytokine production. We conclude that SHM, but not CSR, regulates peripheral B cell tolerance through the production of mutated antibodies that clear antigens and prevent sustained interleukin secretions that interfere with Treg function.

Authors

Tineke Cantaert, Jean-Nicolas Schickel, Jason M. Bannock, Yen-Shing Ng, Christopher Massad, Fabien R. Delmotte, Natsuko Yamakawa, Salome Glauzy, Nicolas Chamberlain, Tuure Kinnunen, Laurence Menard, Aubert Lavoie, Jolan E. Walter, Luigi D. Notarangelo, Julie Bruneau, Waleed Al-Herz, Sara Sebnem Kilic, Hans D. Ochs, Charlotte Cunningham-Rundles, Mirjam van der Burg, Taco W. Kuijpers, Sven Kracker, Hideo Kaneko, Yujin Sekinaka, Shigeaki Nonoyama, Anne Durandy, Eric Meffre

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 Total
Citations: 3 2 6 3 5 4 7 2 32
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2021 (3)

Title and authors Publication Year
Helper T Cells in Idiopathic Membranous Nephropathy
Q Zhao, H Dai, X Liu, H Jiang, W Liu, Z Feng, N Zhang, Y Gao, Z Dong, X Zhou, J Du, N Zhang, H Rui, L Yuan, B Liu
Frontiers in immunology 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
J Aluri, A Bach, S Kaviany, LC Paracatu, M Kitcharoensakkul, MA Walkiewicz, CD Putnam, M Shinawi, N Saucier, EM Rizzi, MT Harmon, MP Keppel, M Ritter, M Similuk, E Kulm, M Joyce, AA de Jesus, R Goldbach-Mansky, YS Lee, M Cella, PL Kendall, MC Dinauer, JJ Bednarski, C Bemrich-Stolz, SW Canna, SM Abraham, MM Demczko, J Powell, SM Jones, AM Scurlock, SS Ravin, JJ Bleesing, JA Connelly, VK Rao, LG Schuettpelz, MA Cooper
Blood 2021
Defective Early B Cell Tolerance Checkpoints in Patients With Systemic Sclerosis Allow the Production of Self Antigen –Specific Clones
S Glauzy, B Olson, C May, D Parisi, C Massad, J Hansen, C Ryu, E Herzog, E Meffre
Arthritis & Rheumatology 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
70 readers on Mendeley
See more details